查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球BETA葡聚醣市场：按来源（谷物,蘑菇,酵母,海藻）,应用（食品和饮料,个人护理,药品,膳食补充剂,动物饲料）和地区（至 2028 年）预测
市场调查报告书
商品编码
1267435

全球BETA葡聚醣市场：按来源（谷物,蘑菇,酵母,海藻）,应用（食品和饮料,个人护理,药品,膳食补充剂,动物饲料）和地区（至 2028 年）预测

Beta-Glucan Market by Source (Cereal, Mushroom, Yeast and Seaweed), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement, Animal Feed), and Region (North America, Europe, APAC, Latin America and RoW) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 260 Pages | 订单完成后即时交付

价格
简介目录

到 2028 年，全球 BETA-葡聚醣市场规模预计将从 2023 年的 5.01 亿美元增长到 7.34 亿美元，预测期内的复合年增长率为 7.9%。

由于对在食品和饮料中使用天然添加剂的需求增加,对高纤维健康食品的消费增加以及人们对 BETA-葡聚醣的健康益处的迅速接受，预计该市场将会增长。 这些因素增加了开发和部署新 BETA-葡聚醣产品的需求。

到 2023 年，谷物部分将占最大份额

与其他食物来源相比，谷物以其相对较高的 BETA-葡聚醣含量而闻名。 例如，燕麦和大麦含有特别高水平的 BETA-葡聚醣，使燕麦成为最丰富的来源之一。 谷物中的 BETA-葡聚醣通常是混合结合物，已被证明具有积极的健康作用，包括免疫调节和降低胆固醇的作用。 谷物富含 BETA-葡聚醣，是提取这种有益化合物的理想来源。

在预测期内，食品和饮料领域将按应用主导市场

按应用划分，预计食品和饮料领域将在预测期内主导市场。 消费者对健康饮食习惯的认识不断提高，以及在麵包店,口香糖,牛奶和蛋白质饮料,即饮饮料等中使用 BETA-葡聚醣，导致 BETA-葡聚醣得到广泛采用。

亚太地区将在 2023 年增长最快

亚太地区预计在预测期内 (2023-2028) 增长最快。 由于中国和印度等亚太国家原材料供应充足，日本和韩国等国家健康食品消费模式不断增强，化妆品使用增加，亚太市场将继续增长未来几年，预计将大幅增长。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 宏观经济指标
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务

第6章行业趋势

  • 简介
  • 价值链分析
  • 供应链
  • 技术分析
  • BETA 葡聚醣市场地图和生态系统
  • 影响客户业务的趋势/颠覆
  • 专利分析
  • 波特的五力分析
  • 案例研究分析
  • 关税和法规的状况
  • 规则
  • 采购流程中的主要利益相关者

第 7 章 BETA 葡聚醣市场：按来源分类

  • 简介
  • 粮食
    • 燕麦
    • 大麦
    • 其他成分
  • 蘑菇
  • 酵母
  • 海藻

第 8 章 Beta 葡聚醣市场：按类别分类

  • 简介
  • 可溶性 BETA 葡聚醣
  • 不溶性BETA-葡聚醣

第 9 章 BETA 葡聚醣市场：按类型

  • 简介
  • 1,3 BETA-葡聚醣
  • 1,4 BETA-葡聚醣
  • 1,6 BETA-葡聚醣

第 10 章 Beta 葡聚醣市场：按应用

  • 简介
  • 食品和饮料
  • 个人护理
  • 医药
  • 膳食补充剂
  • 动物饲料

第 11 章 BETA 葡聚醣市场：按品牌

  • 简介
  • 奥特维尔
  • 宣传
  • SANACEL
  • AVENACARE
  • 营养素
  • 威尔穆恩
  • 耶斯蒂蒙

第 12 章 BETA 葡聚醣市场：按提取方法分类

  • 简介
  • 谷物来源的 BETA-葡聚醣
  • 源自酵母的 BETA 葡聚醣

第 13 章 BETA 葡聚醣市场：按地区分类

  • 简介
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚和新西兰
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 其他地区（ROW）
    • 中东
    • 非洲

第14章竞争格局

  • 概览
  • 市场份额分析
  • 主要公司分部的利润分析
  • 主要公司采用的策略
  • 公司评估象限（主要公司）
  • 商业评估象限（初创公司/中小企业）
  • 产品发布,交易和其他趋势

第十五章公司简介

  • 主要公司
    • TATE & LYLE PLC
    • KERRY GROUP PLC
    • KONINKLIJKE DSM N.V.
    • INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • MERCK
    • LESAFFRE HUMAN CARE
    • KEMIN INDUSTRIES
    • ANGEL YEAST CO., LTD
    • LALLEMAND
    • OHLY GMBH
    • BIORIGIN-ZILOR
    • CEAPRO INC.
    • SPECIALTY BIOTECH CO., LTD.
    • ALLTECH LIFE SCIENCES
    • GLYCONOVA
    • GARUDA INTERNATIONAL INC.
    • VAN WANKUM INGREDIENTS
    • SUPER BETA GLUCAN
    • LEIBER GROUP GMBH & CO KG
    • NUTRISCIENCE INNOVATIONS
    • EMBRIA HEALTH SCIENCES LLC
    • NUTRAQ
    • ABAC R&D AG
    • GLUCAN CORPORATION
    • TRANSFER POINT, INC.

第 16 章相邻和相关市场

  • 简介
  • 研究局限性
  • 饲料香精和甜味剂市场
  • 启动文化市场

第十七章附录

简介目录
Product Code: FB 5113

The beta-glucan market is projected to grow from USD 501 Million in 2023 to USD 734 Million by 2028, at a CAGR of 7.9% during the forecast period. The market is anticipated to grow due to increasing demand for use of natural additives in the food and beverage products, growing consumption of healthy diets with high fiber, rising surge in acceptance for beta-glucan for its several health-benefits. Such factors have driven the need to develop and deploy new products for beta-glucan. D

The segment grain & cereal is expected to account for the largest share in 2023.

Cereals and grains are known for their relatively high beta-glucan content compared to other food sources. For example, oats and barley contain particularly high levels of beta-glucan, with oats being one of the richest dietary sources. The beta-glucans in cereals and grains are typically of the mixed-linkage type, which has been shown to have favorable health effects, such as immune-modulating and cholesterol-lowering properties. The high beta-glucan content of cereals and grains makes them a desirable source for extracting this beneficial compound.

The food and beverage segment is projected to dominate the market in the application segment during the forecast period.

Based on the application segment, the food and beverage segment is projected to dominate the market during the forecast period. The rising awareness among the consumers for healthy diets, use of beta-glucan in bakery, chewing gums, milk and protein beverages, instant drinks and many others has led to the adoption of beta-glucan.

Asia Pacific is expected to account for the fastest market share in 2023.

The beta-glucan market industry has been studied in North America, Europe, Asia Pacific, Latin America and Rest of the World. Asia Pacific accounted for the fastest market during the forecast period of 2023-2028. The Asia Pacific market will experience considerable growth in the next years because of easy availability of raw materials in the Asia Pacific countries such as China and India, growing healthy food consumption patterns and increasing use of cosmetic products in countries like Japan and South Korea.

The break-up of the profile of primary participants in the beta-glucan market:

  • By Value Chain: Manufacturers-85%, Suppliers-15%
  • By Designation: CXOs - 33.7%, Managers - 44%, Executives-22.3%
  • By Region: North America - 60%, Europe - 18%, Asia Pacific - 10%, South America - 8%, and Rest of the World - 4%

Prominent companies include Tate & Lyle PLC (England), Kerry Group PLC (Ireland), Koninklijke DSM NV (Netherlands), International Flavors & Fragrances INC. (US), Merck (US).

Research Coverage:

This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), and region (North America, Europe, Asia Pacific, South America and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the de-oiled lecithin market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing health consciousness among consumers and increasing health expenditure, Growing application of beta-glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunity (Untapped beta-glucan applications), and challenge (Lack of consumer awareness) influencing the growth of the beta-glucan market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the beta-glucan market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Tate & Lyle PLC (England), Kerry Group PLC (Ireland), Koninklijke DSM NV (Netherlands), International Flavors & Fragrances INC. (US) and Merck (US) among others in the beta-glucan market strategies. The report also helps stakeholders understand the starter culture market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • FIGURE 1 MARKET SEGMENTATION
    • 1.3.1 INCLUSIONS & EXCLUSIONS
  • 1.4 REGIONS COVERED
  • 1.5 PERIODIZATION CONSIDERED
  • 1.6 UNITS CONSIDERED
    • 1.6.1 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES, 2017-2022
    • 1.6.2 VOLUME UNIT CONSIDERED
  • 1.7 STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES
    • 1.8.1 RECESSION IMPACT ANALYSIS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 BETA GLUCAN MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 APPROACH ONE: TOP-DOWN
    • FIGURE 3 BETA-GLUCAN MARKET SIZE ESTIMATION - TOP-DOWN APPROACH
    • 2.2.2 APPROACH TWO: BOTTOM-UP
    • FIGURE 4 BETA-GLUCAN MARKET SIZE ESTIMATION - BOTTOM-UP APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 STUDY LIMITATIONS
  • 2.6 RECESSION IMPACT ON BETA-GLUCAN MARKET
    • 2.6.1 MACROECONOMIC INDICATORS OF RECESSION
    • FIGURE 6 INDICATORS OF RECESSION
    • FIGURE 7 GLOBAL INFLATION RATE, 2011-2021
    • FIGURE 8 GLOBAL GDP, 2011-2021 (USD TRILLION)
    • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET
    • FIGURE 10 BETA-GLUCAN MARKET: PREVIOUS FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • FIGURE 11 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 BETA-GLUCAN MARKET SNAPSHOT, BY REGION

4 PREMIUM INSIGHTS

  • 4.1 BRIEF OVERVIEW OF BETA-GLUCAN MARKET
    • FIGURE 15 GROWTH IN HEALTH-CONSCIOUS POPULATION TO DRIVE BETA-GLUCAN MARKET
  • 4.2 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE & COUNTRY
    • FIGURE 16 GRAINS & CEREALS AND US DOMINATED RESPECTIVE SEGMENTS IN NORTH AMERICAN MARKET IN 2022
  • 4.3 BETA-GLUCAN MARKET, BY APPLICATION & REGION
    • FIGURE 17 FOOD & BEVERAGE SEGMENT DOMINATED MARKET ACROSS ALL REGIONS IN 2022 (USD MILLION)
  • 4.4 BETA-GLUCAN MARKET, BY KEY COUNTRY
    • FIGURE 18 CHINA AND INDIA TO BE MOST LUCRATIVE MARKETS FOR BETA-GLUCAN
  • 4.5 BETA-GLUCAN MARKET, BY CATEGORY
    • FIGURE 19 NORTH AMERICA TO DOMINATE BETA-GLUCAN MARKET AMONG ALL REGIONS THROUGH FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
    • FIGURE 20 NUMBER OF NEW CANCER CASES FOR ALL AGES, 2015-2020 (MILLION)
    • 5.2.2 INCREASE IN CONSUMPTION OF DIETARY FIBERS
  • 5.3 MARKET DYNAMICS
    • FIGURE 21 MARKET DYNAMICS: BETA-GLUCAN MARKET
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growth in health consciousness among consumers and increasing health expenditure
    • FIGURE 22 INCREASING PER CAPITA HEALTH EXPENDITURE IN MAJOR ECONOMIES, 2015-2019 (USD)
      • 5.3.1.2 Increase in application of beta-glucan in different industries
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Inconsistency in regulatory norms governing beta-glucan
      • 5.3.2.2 Price volatility of raw materials
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Untapped beta-glucan applications
      • 5.3.3.2 Rise in demand for natural and plant-based ingredients
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Lack of consumer awareness regarding benefits specific to beta-glucan

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN ANALYSIS
    • 6.2.1 RESEARCH & DEVELOPMENT AND RAW MATERIAL SOURCING
    • 6.2.2 MANUFACTURING
    • 6.2.3 DISTRIBUTION
    • 6.2.4 END USERS
    • FIGURE 23 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS
  • 6.3 SUPPLY CHAIN
    • FIGURE 24 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS
    • 6.3.1 SMOOTH PROCUREMENT OF RAW MATERIALS
    • 6.3.2 DISTRIBUTION CHANNELS TO REDUCE DEMAND-SUPPLY GAP
  • 6.4 TECHNOLOGY ANALYSIS
    • 6.4.1 ENCAPSULATION
    • 6.4.2 NEW AVENUES OF YEAST CULTURE & EXTRACTION
  • 6.5 BETA-GLUCAN MARKET MAP AND ECOSYSTEM
    • 6.5.1 DEMAND SIDE
    • 6.5.2 SUPPLY SIDE
    • FIGURE 25 BETA-GLUCAN MARKET: ECOSYSTEM MAP
    • 6.5.3 ECOSYSTEM MAP
    • TABLE 2 BETA-GLUCAN MARKET ECOSYSTEM
  • 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 6.6.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN BETA-GLUCAN MARKET
    • FIGURE 26 REVENUE SHIFT IMPACTING TRENDS/DISRUPTIONS IN BETA-GLUCAN MARKET
  • 6.7 PATENT ANALYSIS
    • FIGURE 27 PATENT ANALYSIS FOR BETA-GLUCAN MARKET, 2012-2022
    • FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN, 2012-2022
    • 6.7.1 LIST OF MAJOR PATENTS
  • 6.8 PORTER'S FIVE FORCES ANALYSIS
    • 6.8.1 THREAT OF NEW ENTRANTS
    • 6.8.2 THREAT OF SUBSTITUTES
    • 6.8.3 BARGAINING POWER OF SUPPLIERS
    • 6.8.4 BARGAINING POWER OF BUYERS
    • 6.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.9 CASE STUDY ANALYSIS
    • 6.9.1 CARGILL, INC.: INVESTMENT OF USD 35 MILLION IN EUROPE
    • 6.9.2 TATE & LYLE PLC: EXTENDING ITS DISTRIBUTION PARTNERSHIP
  • 6.10 TARIFF AND REGULATORY LANDSCAPE
    • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.10.1.1 North America
    • TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.10.1.2 Europe
    • TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.10.1.3 Asia Pacific
    • TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.10.1.4 RoW
    • TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.11 REGULATIONS
    • 6.11.1 INTRODUCTION
    • 6.11.2 NORTH AMERICA
      • 6.11.2.1 US Food and Drug Administration (21CFR101.14)
      • 6.11.2.2 US Food and Drug Administration (21CFR101.81)
    • 6.11.3 EUROPEAN FOOD SAFETY AUTHORITY
    • 6.11.4 EUROPEAN UNION
  • 6.12 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.12.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
    • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
    • 6.12.2 BUYING CRITERIA
    • FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS
    • TABLE 8 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS

7 BETA-GLUCAN MARKET, BY SOURCE

  • 7.1 INTRODUCTION
    • FIGURE 31 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION)
    • TABLE 9 BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 10 BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 11 BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 12 BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
  • 7.2 CEREALS & GRAINS
    • TABLE 13 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 14 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 15 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018-2022 (TON)
    • TABLE 16 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023-2028 (TON)
    • 7.2.1 OATS
      • 7.2.1.1 Increase in awareness of health benefits of beta-glucan from oats
    • 7.2.2 BARLEY
      • 7.2.2.1 Diverse applications of barley-based beta-glucan in various industries
    • 7.2.3 OTHER SOURCES
  • 7.3 MUSHROOM
    • 7.3.1 D-GLUCAN FROM MUSHROOMS CATERS TO GROWTH IN DEMAND FOR IMMUNE SYSTEM-SUPPORTING INGREDIENTS
    • TABLE 17 MUSHROOM SOURCES MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 18 MUSHROOM SOURCES MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 19 MUSHROOM SOURCES MARKET, BY REGION, 2018-2022 (TON)
    • TABLE 20 MUSHROOM SOURCES MARKET, BY REGION, 2023-2028 (TON)
  • 7.4 YEAST
    • 7.4.1 GOVERNMENT SUPPORT FOR RESEARCH & DEVELOPMENT ON YEAST-BASED BETA-GLUCAN
    • TABLE 21 YEAST SOURCES MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 22 YEAST SOURCES MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 23 YEAST SOURCES MARKET, BY REGION, 2018-2022 (TON)
    • TABLE 24 YEAST SOURCES MARKET, BY REGION, 2023-2028 (TON)
  • 7.5 SEAWEED
    • 7.5.1 GROWING USE OF SEAWEED-BASED BETA-GLUCAN IN COSMETIC AND PERSONAL CARE PRODUCTS
    • TABLE 25 SEAWEED SOURCES MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 26 SEAWEED SOURCES MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 27 SEAWEED SOURCES MARKET, BY REGION, 2018-2022 (TON)
    • TABLE 28 SEAWEED SOURCES MARKET, BY REGION, 2023-2028 (TON)

8 BETA-GLUCAN MARKET, BY CATEGORY

  • 8.1 INTRODUCTION
    • FIGURE 32 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION)
    • TABLE 29 BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 30 GLOBAL BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
  • 8.2 SOLUBLE BETA-GLUCAN
    • 8.2.1 RISE IN PREVALENCE OF CHRONIC LIFESTYLE DISEASES
    • TABLE 31 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 32 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.3 INSOLUBLE BETA-GLUCAN
    • 8.3.1 POSITIVE EFFECTS OF INSOLUBLE BETA-GLUCAN ON HUMAN HEALTH
    • TABLE 33 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 34 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023-2028 (USD MILLION)

9 BETA-GLUCAN MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 1,3 BETA-GLUCAN
  • 9.3 1,4 BETA-GLUCAN
  • 9.4 1,6 BETA-GLUCAN

10 BETA-GLUCAN MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • TABLE 35 APPLICATION OVERVIEW
    • FIGURE 33 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • TABLE 36 BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 37 BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • 10.2 FOOD & BEVERAGES
    • 10.2.1 BENEFITS OF DIET INCLUDING SOLUBLE FIBER IN MANAGING CHRONIC CONDITIONS
    • TABLE 38 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 39 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2023-2028 (USD MILLION)
  • 10.3 PERSONAL CARE
    • 10.3.1 CONSUMERS' DEMAND FOR NATURAL AND HEALTH INGREDIENTS IN PERSONAL CARE PRODUCTS
    • TABLE 40 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 41 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2023-2028 (USD MILLION)
  • 10.4 PHARMACEUTICALS
    • 10.4.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS
    • TABLE 42 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 43 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2023-2028 (USD MILLION)
  • 10.5 DIETARY SUPPLEMENTS
    • 10.5.1 INCREASE IN AWARENESS OF ASSOCIATED HEALTH BENEFITS
    • TABLE 44 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 45 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2023-2028 (USD MILLION)
  • 10.6 ANIMAL FEED
    • 10.6.1 GROWING INCLINATION OF PET AND LIVESTOCK OWNERS TOWARD NUTRITIOUS FEED
    • TABLE 46 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 47 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2023-2028 (USD MILLION)

11 BETA-GLUCAN MARKET, BY BRAND

  • 11.1 INTRODUCTION
  • 11.2 OATWELL
  • 11.3 PROMOAT
  • 11.4 SANACEL
  • 11.5 AVENACARE
  • 11.6 NUTRIM
  • 11.7 WELLMUNE
  • 11.8 YESTIMUN

12 BETA-GLUCAN MARKET, BY EXTRACTION METHOD

  • 12.1 INTRODUCTION
    • TABLE 48 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES
  • 12.2 BETA-GLUCAN FROM CEREAL
  • 12.3 BETA-GLUCAN FROM YEAST

13 BETA-GLUCAN MARKET, BY REGION

  • 13.1 INTRODUCTION
    • FIGURE 34 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2023-2028
    • TABLE 49 GLOBAL BETA-GLUCAN MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 50 BETA-GLUCAN MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 51 BETA-GLUCAN MARKET, BY REGION, 2018-2022 (TON)
    • TABLE 52 BETA-GLUCAN MARKET, BY REGION, 2023-2028 (TON)
  • 13.2 NORTH AMERICA
    • FIGURE 35 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT
    • 13.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 36 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017-2021
    • FIGURE 37 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 53 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 54 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • TABLE 55 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 56 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 58 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
    • TABLE 59 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 60 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 61 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 62 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • 13.2.2 US
      • 13.2.2.1 Rise in awareness and consumption of fiber-rich ingredient-based products
    • TABLE 63 US: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 64 US: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 65 US: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 66 US: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.2.3 CANADA
      • 13.2.3.1 Increased potential usage in food & beverage and pharmaceutical applications in Canada
    • TABLE 67 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 68 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 69 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 70 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.2.4 MEXICO
      • 13.2.4.1 Support from government initiatives and public healthcare campaigns
    • TABLE 71 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 72 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 73 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 74 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • 13.3 EUROPE
    • 13.3.1 EUROPE: RECESSION IMPACT
    • FIGURE 38 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017-2021
    • FIGURE 39 EUROPE: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 75 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 76 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • TABLE 77 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 78 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 79 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 80 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
    • TABLE 81 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 82 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 83 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 84 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • 13.3.2 GERMANY
      • 13.3.2.1 Rise in prevalence of diabetes and population inclining toward natural ingredient-based foods
    • TABLE 85 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 86 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 87 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 88 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.3.3 FRANCE
      • 13.3.3.1 Demand for functional foods in France
    • TABLE 89 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 90 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 91 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 92 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.3.4 UK
      • 13.3.4.1 Growth in natural ingredient trend in UK
    • TABLE 93 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 94 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 95 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 96 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.3.5 ITALY
      • 13.3.5.1 Significant rise in consumer demand for health-enriching ingredients in Italy
    • TABLE 97 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 98 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 99 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 100 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.3.6 SPAIN
      • 13.3.6.1 Rise in consumer awareness toward consumption of organic ingredients
    • TABLE 101 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 102 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 103 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 104 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.3.7 REST OF EUROPE
    • TABLE 105 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 106 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 107 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 108 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • 13.4 ASIA PACIFIC
    • 13.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 40 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017-2021
    • FIGURE 41 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
    • FIGURE 42 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT
    • TABLE 109 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 114 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
    • TABLE 115 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • 13.4.2 CHINA
      • 13.4.2.1 Rise in preference for fortified products in China
    • TABLE 119 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 120 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 121 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 122 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.4.3 INDIA
      • 13.4.3.1 Innovation and product development in beta-glucan industry in India
    • TABLE 123 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 124 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 125 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 126 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.4.4 JAPAN
      • 13.4.4.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures in Japan
    • TABLE 127 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 128 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 129 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 130 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.4.5 AUSTRALIA & NEW ZEALAND
      • 13.4.5.1 High spending capacity on nutritional products in ANZ
    • TABLE 131 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 132 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 133 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 134 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.4.6 REST OF ASIA PACIFIC
    • TABLE 135 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 136 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 137 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 138 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • 13.5 SOUTH AMERICA
    • 13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 43 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017-2021
    • FIGURE 44 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 139 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 140 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • TABLE 141 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 142 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 143 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 144 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
    • TABLE 145 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 146 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 147 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 148 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • 13.5.2 BRAZIL
      • 13.5.2.1 Development of food & beverage industry due to inflow of FDI
    • TABLE 149 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 150 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 151 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 152 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.5.3 ARGENTINA
      • 13.5.3.1 Increase in consumer awareness regarding health benefits of beta-glucan in Argentina
    • FIGURE 45 ARGENTINA: HEALTH EXPENDITURE (SHARE OF GDP), 2012-2017
    • TABLE 153 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 154 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 155 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 156 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.5.4 REST OF SOUTH AMERICA
    • TABLE 157 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 158 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 159 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 160 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • 13.6 REST OF THE WORLD (ROW)
    • 13.6.1 ROW: RECESSION IMPACT
    • FIGURE 46 ROW: INFLATION RATES, BY KEY COUNTRY, 2017-2021
    • FIGURE 47 ROW: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 161 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 162 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • TABLE 163 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (USD MILLION)
    • TABLE 164 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (USD MILLION)
    • TABLE 165 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018-2022 (TON)
    • TABLE 166 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023-2028 (TON)
    • TABLE 167 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 168 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 169 ROW: BETA-GLUCAN MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 170 ROW: BETA-GLUCAN MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 13.6.2 MIDDLE EAST
      • 13.6.2.1 Increased health and wellness initiatives in Middle East
    • TABLE 171 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 172 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 173 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 174 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
    • 13.6.3 AFRICA
      • 13.6.3.1 Growing demand for natural and functional ingredients in Africa
    • TABLE 175 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018-2022 (USD MILLION)
    • TABLE 176 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023-2028 (USD MILLION)
    • TABLE 177 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 178 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023-2028 (USD MILLION)

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 MARKET SHARE ANALYSIS
    • TABLE 179 BETA-GLUCAN MARKET: DEGREE OF COMPETITION (FRAGMENTED), 2022
  • 14.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS
    • FIGURE 48 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2018-2022 (USD MILLION)
  • 14.4 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 180 STRATEGIES ADOPTED BY KEY BETA-GLUCAN MANUFACTURERS
  • 14.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
    • 14.5.1 STARS
    • 14.5.2 EMERGING LEADERS
    • 14.5.3 PERVASIVE PLAYERS
    • 14.5.4 PARTICIPANTS
    • FIGURE 49 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (KEY PLAYERS)
    • 14.5.5 PRODUCT FOOTPRINT
    • TABLE 181 COMPANY FOOTPRINT, BY SOURCE
    • TABLE 182 COMPANY FOOTPRINT, BY APPLICATION
    • TABLE 183 COMPANY FOOTPRINT, BY REGION
    • TABLE 184 OVERALL COMPANY FOOTPRINT
  • 14.6 COMPANY EVALUATION QUADRANT (STARTUPS/SMES)
    • 14.6.1 PROGRESSIVE COMPANIES
    • 14.6.2 STARTING BLOCKS
    • 14.6.3 RESPONSIVE COMPANIES
    • 14.6.4 DYNAMIC COMPANIES
    • FIGURE 50 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (STARTUPS/SMES)
    • 14.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
    • TABLE 185 BETA-GLUCAN MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 186 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 14.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
    • 14.7.1 PRODUCT LAUNCHES
    • 14.7.2 DEALS
    • TABLE 187 BETA-GLUCAN MARKET: DEALS, 2018-2022
    • 14.7.3 OTHER DEVELOPMENTS
    • TABLE 188 BETA-GLUCAN MARKET: OTHER DEVELOPMENTS, 2018-2022

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 15.1.1 TATE & LYLE PLC
    • TABLE 189 TATE & LYLE PLC: BUSINESS OVERVIEW
    • FIGURE 51 TATE & LYLE PLC: COMPANY SNAPSHOT
    • TABLE 190 TATE & LYLE PLC: PRODUCTS OFFERED
    • TABLE 191 TATE & LYLE PLC: DEALS
    • TABLE 192 TATE & LYLE PLC: OTHER DEVELOPMENTS
    • 15.1.2 KERRY GROUP PLC
    • TABLE 193 KERRY GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT
    • TABLE 194 KERRY GROUP PLC: PRODUCTS OFFERED
    • 15.1.3 KONINKLIJKE DSM N.V.
    • TABLE 195 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
    • FIGURE 53 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
    • TABLE 196 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
    • TABLE 197 KONINKLIJKE DSM N.V.: OTHER DEVELOPMENTS
    • 15.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • TABLE 198 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
    • FIGURE 54 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
    • TABLE 199 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED
    • TABLE 200 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
    • TABLE 201 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS
    • 15.1.5 MERCK
    • TABLE 202 MERCK: BUSINESS OVERVIEW
    • FIGURE 55 MERCK: COMPANY SNAPSHOT
    • TABLE 203 MERCK: PRODUCTS OFFERED
    • TABLE 204 MERCK: OTHER DEVELOPMENTS
    • 15.1.6 LESAFFRE HUMAN CARE
    • TABLE 205 LESAFFRE HUMAN CARE: BUSINESS OVERVIEW
    • TABLE 206 LESAFFRE HUMAN CARE: PRODUCTS OFFERED
    • TABLE 207 LESAFFRE HUMAN CARE: DEALS
    • 15.1.7 KEMIN INDUSTRIES
    • TABLE 208 KEMIN INDUSTRIES: BUSINESS OVERVIEW
    • TABLE 209 KEMIN INDUSTRIES: PRODUCTS OFFERED
    • TABLE 210 KEMIN INDUSTRIES OTHER DEVELOPMENTS
    • 15.1.8 ANGEL YEAST CO., LTD
    • TABLE 211 ANGEL YEAST CO., LTD: BUSINESS OVERVIEW
    • FIGURE 56 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT
    • TABLE 212 ANGEL YEAST CO., LTD: PRODUCTS OFFERED
    • 15.1.9 LALLEMAND
    • TABLE 213 LALLEMAND: BUSINESS OVERVIEW
    • TABLE 214 LALLEMAND: PRODUCTS OFFERED
    • TABLE 215 LALLEMAND: DEALS
    • 15.1.10 OHLY GMBH
    • TABLE 216 OHLY GMBH: BUSINESS OVERVIEW
    • TABLE 217 OHLY GMBH: PRODUCTS OFFERED
    • 15.1.11 BIORIGIN - ZILOR
    • TABLE 218 BIORIGIN - ZILOR: BUSINESS OVERVIEW
    • TABLE 219 BIORIGIN - ZILOR: PRODUCTS OFFERED
    • 15.1.12 CEAPRO INC.
    • TABLE 220 CEAPRO INC: BUSINESS OVERVIEW
    • FIGURE 57 CEAPRO INC.: COMPANY SNAPSHOT
    • TABLE 221 CEAPRO INC: PRODUCT OFFERED
    • TABLE 222 CEAPRO INC: DEALS
    • TABLE 223 CEAPRO INC: OTHER DEVELOPMENTS
    • 15.1.13 SPECIALTY BIOTECH CO., LTD.
    • TABLE 224 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW
    • TABLE 225 SPECIALTY BIOTECH CO., LTD.: PRODUCTS OFFERED
    • 15.1.14 ALLTECH LIFE SCIENCES
    • TABLE 226 ALLTECH LIFE SCIENCES: BUSINESS OVERVIEW
    • TABLE 227 ALLTECH LIFE SCIENCES: PRODUCTS OFFERED
    • 15.1.15 GLYCONOVA
    • TABLE 228 GLYCONOVA: BUSINESS OVERVIEW
    • TABLE 229 GLYCONOVA: PRODUCTS OFFERED
    • 15.1.16 GARUDA INTERNATIONAL INC.
    • TABLE 230 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW
    • 15.1.17 VAN WANKUM INGREDIENTS
    • TABLE 231 VAN WANKUM INGREDIENTS: BUSINESS OVERVIEW
    • TABLE 232 VAN WANKUM INGREDIENTS: PRODUCTS OFFERED
    • 15.1.18 SUPER BETA GLUCAN
    • TABLE 233 SUPER BETA GLUCAN: BUSINESS OVERVIEW
    • TABLE 234 SUPER BETA GLUCAN: PRODUCTS OFFERED
    • 15.1.19 LEIBER GROUP GMBH & CO KG
    • TABLE 235 LEIBER GROUP GMBH & CO KG: BUSINESS OVERVIEW
    • TABLE 236 LEIBER GROUP GMBH & CO KG: PRODUCTS OFFERED
    • 15.1.20 NUTRISCIENCE INNOVATIONS
    • TABLE 237 NUTRISCIENCE INNOVATIONS: BUSINESS OVERVIEW
    • TABLE 238 NUTRISCIENCE INNOVATIONS: PRODUCTS OFFERED
    • 15.1.21 EMBRIA HEALTH SCIENCES LLC
    • 15.1.22 NUTRAQ
    • 15.1.23 ABAC R&D AG
    • 15.1.24 GLUCAN CORPORATION
    • 15.1.25 TRANSFER POINT, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

16 ADJACENT & RELATED MARKETS

  • 16.1 INTRODUCTION
    • TABLE 239 ADJACENT MARKETS
  • 16.2 STUDY LIMITATIONS
  • 16.3 FEED FLAVORS AND SWEETENERS MARKET
    • 16.3.1 MARKET DEFINITION
    • 16.3.2 MARKET OVERVIEW
    • TABLE 240 FEED SWEETENERS MARKET, BY TYPE, 2015-2022 (USD MILLION)
    • TABLE 241 FEED SWEETENERS MARKET, BY TYPE, 2015-2022 (KT)
  • 16.4 STARTER CULTURE MARKET
    • 16.4.1 MARKET DEFINITION
    • 16.4.2 MARKET OVERVIEW
    • TABLE 242 STARTER CULTURE MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 243 STARTER CULTURE MARKET, BY APPLICATION, 2022-2027 (USD MILLION)

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 AUTHOR DETAILS